Oral candidiasis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 8: | Line 8: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category: | [[Category:Disease]] | ||
[[Category:Fungal diseases]] | [[Category:Fungal diseases]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] |
Revision as of 14:37, 2 January 2013
Oral candidiasis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Oral candidiasis secondary prevention On the Web |
American Roentgen Ray Society Images of Oral candidiasis secondary prevention |
Risk calculators and risk factors for Oral candidiasis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Nosocomial disease surveillance is conducted by NNIS in selected hospitals. Active population-based surveillance for candidemia is being conducted in selected U.S. sites.